by McDermott + Bull | Jun 2, 2021 | Ken Dropiewski, White Paper
THE NEW NORMAL: WHAT BUSINESS TRAVEL WILL LOOK LIKE FOR EXECUTIVES Over the past six months, I’ve had the opportunity to speak with executives in the life science and medtech space about the reduction in business travel due to the pandemic. We talked about what it has...
by McDermott + Bull | May 17, 2021 | Chris Bull, Ken Dropiewski, Placement Announcement
McDermott + Bull has successfully placed Navesh Kandiyil as the Vice President of Respiratory Business + Clinical Programs and Tom Hendrix as Market Vice President for Apria Healthcare. As the Vice President of Respiratory Business + Clinical Programs, Navesh will...
by McDermott + Bull | Apr 15, 2021 | Chris Bull, Ken Dropiewski, Placement Announcement
McDermott + Bull has successfully placed Steven Cha as the Chief Medical Officer at NKMax America, Inc. Steven will provide leadership and direction for the company’s pipeline of clinical development programs in cellular therapy. He will be a key member of the senior...
by Tori Leets | Apr 8, 2021 | Ken Dropiewski, Measure Up Monday
Every Monday, McDermott + Bull Managing Director Ken Dropiewski shares mindset tips to provide insight on self development in your personal and professional life. Click on the arrows below to read more. MEASURE UP...
by Tori Leets | Jan 26, 2021 | Ken Dropiewski, Placement Announcement
McDermott + Bull has successfully placed Amani Farid as the Senior Director of Clinical Development at RapidAI. Amani will be responsible for building the corporate development process as well as capturing acquisition and partnership opportunities. She will discover,...
by McDermott + Bull | Jan 22, 2021 | Ken Dropiewski, White Paper
I remember leaving the J.P. Morgan Health Care Conference last January with a sense of optimism. We knew the POTUS was going to do everything in his power to keep the economy strong to help his chance for re-election. Well, we all know what happened with the pandemic,...
